A. Amphoux, M. J. Millan, A. Cordi, H. Bonisch, V. Vialou et al., Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1-and alpha 2-adrenoceptor subtypes, Eur J Pharmacol, vol.634, pp.1-9, 2010.

A. Amphoux, V. Vialou, E. Drescher, M. Bruss, C. M. La-cour et al., Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain, Neuropharmacology, vol.50, pp.941-952, 2006.

N. Aoyama, N. Takahashi, K. Kitaichi, R. Ishihara, S. Saito et al., Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder, Alcohol Clin Exp Res, vol.30, pp.1644-1649, 2006.

A. Bacq, L. Balasse, G. Biala, B. Guiard, A. M. Gardier et al., Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response, Mol Psychiatry, vol.17, pp.926-939, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00661249

N. L. Baganz, R. E. Horton, A. S. Calderon, W. A. Owens, J. L. Munn et al., Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice, Proc Natl Acad Sci U S A, vol.105, pp.18976-18981, 2008.

N. Baganz, R. Horton, K. Martin, A. Holmes, and L. C. Daws, Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun, J Neurosci, vol.30, pp.15185-15195, 2010.

J. Beique, C. De-montigny, P. Blier, and G. Debonnel, Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat, Neuropharmacology, vol.39, pp.1800-1812, 2000.

D. Bengel, D. L. Murphy, A. M. Andrews, C. H. Wichems, D. Feltner et al., Altered brain serotonin homeostasis and locomotor insensitivity to 3,4methylenedioxymethamphetamine ("ecstasy") in serotonin transporter-deficient mice, Mol Pharmacol, vol.53, pp.649-655, 1998.

H. Bonisch, Extraneuronal transport of catecholamines, Pharmacology, vol.21, pp.93-108, 1980.

T. Breidert, F. Spitzenberger, D. Grundemann, and E. Schomig, Catecholamine transport by the organic cation transporter type 1 (OCT1), Br J Pharmacol, vol.125, pp.218-224, 1998.

T. Budiman, E. Bamberg, H. Koepsell, and G. Nagel, Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat, J Biol Chem, vol.275, pp.29413-29420, 2000.

M. A. Bunin and R. M. Wightman, Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission, J Neurosci, vol.18, pp.4854-4860, 1998.

A. E. Busch, U. Karbach, D. Miska, V. Gorboulev, A. Akhoundova et al., Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine, Mol Pharmacol, vol.54, pp.342-352, 1998.

D. S. Charney, Monoamine dysfunction and the pathophysiology and treatment of depression, J Clin Psychiatry, vol.59, pp.11-14, 1998.

G. Ciarimboli, T. Ludwig, D. Lang, H. Pavenstadt, H. Koepsell et al., Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2, Am J Pathol, vol.167, pp.1477-1484, 2005.

T. Couroussé, A. Bacq, C. Belzung, B. Guiard, L. Balasse et al., Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3beta signaling, Mol Psychiatry, 2014.

M. Cui, R. Aras, W. V. Christian, P. M. Rappold, M. Hatwar et al., The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway, Proc Natl Acad Sci U S A, vol.106, pp.8043-8048, 2009.

D. J. David, B. A. Samuels, Q. Rainer, J. W. Wang, D. Marsteller et al., Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety/depression, Neuron, vol.62, pp.479-493, 2009.

L. C. Daws, S. Montanez, W. A. Owens, G. G. Gould, A. Frazer et al., Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry, J Neurosci Methods, vol.143, pp.49-62, 2005.

E. R. De-kloet, M. Joels, and F. Holsboer, Stress and the brain: from adaptation to disease, Nat Rev Neurosci, vol.6, pp.463-475, 2005.

W. C. Drevets, Neuroimaging studies of mood disorders, Biol Psychiatry, vol.48, pp.813-829, 2000.

H. Duan and J. Wang, Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3, J Pharmacol Exp Ther, vol.335, pp.743-753, 2010.

K. Engel, M. Zhou, and J. Wang, Identification and characterization of a novel monoamine transporter in the human brain, J Biol Chem, vol.279, pp.50042-50049, 2004.

N. Feng, C. A. Lowry, J. L. Lukkes, M. Orchinik, G. L. Forster et al., Organic cation transporter inhibition increases medial hypothalamic serotonin under basal conditions and during mild restraint, Brain Res, vol.1326, pp.105-113, 2010.

L. F. Fontenelle, M. V. Mendlowicz, and M. Versiani, The descriptive epidemiology of obsessive-compulsive disorder, Prog Neuropsychopharmacol Biol Psychiatry, vol.30, pp.327-337, 2006.

P. J. Gasser, C. A. Lowry, and M. Orchinik, Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission, J Neurosci, vol.26, pp.8758-8766, 2006.

P. J. Gasser, M. Orchinik, I. Raju, and C. A. Lowry, Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain, J Comp Neurol, vol.512, pp.529-555, 2009.

J. S. Goodwin, G. A. Larson, J. Swant, N. Sen, J. A. Javitch et al., Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo, J Biol Chem, vol.284, pp.2978-2989, 2009.

K. B. Goralski, G. Lou, M. T. Prowse, V. Gorboulev, C. Volk et al., The cation transporters rOCT1 and rOCT2 interact with bicarbonate but play only a minor role for amantadine uptake into rat renal proximal tubules, J Pharmacol Exp Ther, vol.303, pp.959-968, 2002.

V. Gorboulev, N. Shatskaya, C. Volk, and H. Koepsell, Subtype-specific affinity for corticosterone of rat organic cation transporters rOCT1 and rOCT2 depends on three amino acids within the substrate binding region, Mol Pharmacol, vol.67, pp.1612-1619, 2005.

V. Gorboulev, J. C. Ulzheimer, A. Akhoundova, I. Ulzheimer-teuber, U. Karbach et al., Cloning and characterization of two human polyspecific organic cation transporters, DNA Cell Biol, vol.16, pp.871-881, 1997.

S. L. Gourley, F. J. Wu, D. D. Kiraly, J. E. Ploski, A. T. Kedves et al., Regionally specific regulation of ERK MAP kinase in a model of antidepressantsensitive chronic depression, Biol Psychiatry, vol.63, pp.353-359, 2008.

K. Graefe and H. Bonisch, The Transport of Amines Across the Axonal Membranes of Noradrenergic and Dopaminergic Neurons, vol.90, 1988.

E. N. Graf, R. A. Wheeler, D. A. Baker, A. L. Ebben, J. E. Hill et al., Corticosterone acts in the nucleus accumbens to enhance dopamine signaling and potentiate reinstatement of cocaine seeking, J Neurosci, vol.33, pp.11800-11810, 2013.

D. Grundemann, J. Babin-ebell, F. Martel, N. Ording, A. Schmidt et al., Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells, J Biol Chem, vol.272, pp.10408-10413, 1997.

D. Grundemann, V. Gorboulev, S. Gambaryan, M. Veyhl, and H. Koepsell, Drug excretion mediated by a new prototype of polyspecific transporter, Nature, vol.372, pp.549-552, 1994.

D. Grundemann, S. Koster, N. Kiefer, T. Breidert, M. Engelhardt et al., Transport of monoamine transmitters by the organic cation transporter type 2, OCT2, J Biol Chem, vol.273, pp.30915-30920, 1998.

D. Grundemann, G. Liebich, N. Kiefer, S. Koster, and E. Schomig, Selective substrates for non-neuronal monoamine transporters, Mol Pharmacol, vol.56, pp.1-10, 1999.

D. Grundemann, B. Schechinger, G. A. Rappold, and E. Schomig, Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter, Nat Neurosci, vol.1, pp.349-351, 1998.

C. Haag, R. Berkels, D. Grundemann, A. Lazar, D. Taubert et al., The localisation of the extraneuronal monoamine transporter (EMT) in rat brain, J Neurochem, vol.88, pp.291-297, 2004.

B. Haenisch, E. Drescher, L. Thiemer, H. Xin, B. Giros et al., Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3, Naunyn Schmiedebergs Arch Pharmacol, vol.385, pp.1017-1023, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01542339

M. Hayer-zillgen, M. Bruss, and H. Bonisch, Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3, Br J Pharmacol, vol.136, pp.829-836, 2002.

L. K. Heisler, H. M. Chu, T. J. Brennan, J. A. Danao, P. Bajwa et al., Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice, Proc Natl Acad Sci U S A, vol.95, pp.15049-15054, 1998.

E. D. Hendley, K. M. Taylor, and S. H. Snyder, 3H-normetanephrine uptake in rat brain slices. Relationship to extraneuronal accumulation of norepinephrine, Eur J Pharmacol, vol.12, pp.167-179, 1970.

R. E. Horton, D. M. Apple, W. A. Owens, N. L. Baganz, S. Cano et al., , 2013.

, Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression, J Neurosci, vol.33, pp.10534-10543

L. L. Iversen, The uptake of catecholamines at high perfusion concentrations in the rat isolated heart: a novel catechol amine uptake process, Br J Pharmacol, vol.25, pp.18-33, 1965.

J. W. Jonker, E. Wagenaar, C. A. Mol, M. Buitelaar, H. Koepsell et al., Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene, Mol Cell Biol, vol.21, pp.5471-5477, 2001.

J. W. Jonker, E. Wagenaar, S. Van-eijl, and A. H. Schinkel, Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations, Mol Cell Biol, vol.23, pp.7902-7908, 2003.

F. Karege, N. Perroud, S. Burkhardt, M. Schwald, E. Ballmann et al., Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims, Biol Psychiatry, vol.61, pp.240-245, 2007.

R. Kekuda, P. D. Prasad, X. Wu, H. Wang, Y. J. Fei et al., Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta, J Biol Chem, vol.273, pp.15971-15979, 1998.

N. Kimura, S. Masuda, Y. Tanihara, H. Ueo, M. Okuda et al., Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1, Drug Metab Pharmacokinet, vol.20, pp.379-386, 2005.

K. Kitaichi, M. Fukuda, H. Nakayama, N. Aoyama, Y. Ito et al., Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice, Neurosci Lett, vol.382, pp.195-200, 2005.

H. Koepsell, V. Gorboulev, U. Karbach, and P. Arndt, Polyspecific cation transporters in the proximal tubule, Nephrol Dial Transplant, vol.15, pp.3-4, 2000.

H. Koepsell, K. Lips, and C. Volk, Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications, Pharm Res, vol.24, pp.1227-1251, 2007.

H. Koepsell, B. M. Schmitt, and V. Gorboulev, Organic cation transporters, Rev Physiol Biochem Pharmacol, vol.150, pp.36-90, 2003.

M. B. Larsen, M. S. Sonders, O. V. Mortensen, G. A. Larson, N. R. Zahniser et al., Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation, J Neurosci, vol.31, pp.6605-6615, 2011.

A. Lazar, S. Walitza, A. Jetter, M. Gerlach, A. Warnke et al., Novel mutations of the extraneuronal monoamine transporter gene in children and adolescents with obsessive-compulsive disorder, Int J Neuropsychopharmacol, vol.11, pp.35-48, 2008.

S. J. Lupien, B. S. Mcewen, M. R. Gunnar, and C. Heim, Effects of stress throughout the lifespan on the brain, behaviour and cognition, Nat Rev Neurosci, vol.10, pp.434-445, 2009.

V. Massmann, B. Edemir, E. Schlatter, R. Al-monajjed, S. Harrach et al., The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3, Pflugers Arch, vol.466, pp.517-527, 2014.

C. M. Mazure, M. L. Bruce, P. K. Maciejewski, and S. C. Jacobs, Adverse life events and cognitive-personality characteristics in the prediction of major depression and antidepressant response, Am J Psychiatry, vol.157, pp.896-903, 2000.

M. J. Millan, The neurobiology and control of anxious states, Prog Neurobiol, vol.70, pp.83-244, 2003.

G. Minuesa, C. Volk, M. Molina-arcas, V. Gorboulev, I. Erkizia et al., Transport of lamivudine [(?)-beta-L-2?,3?-dideoxy-3?-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3, J Pharmacol Exp Ther, vol.329, pp.252-261, 2009.

S. E. Mireylees, N. T. Brammer, and G. A. Buckley, A kinetic study of the in vitro uptake of [3H]dopamine over a wide range of concentrations by rat striatal preparations, Biochem Pharmacol, vol.35, pp.4065-4071, 1986.

K. Mitchell, A. F. Oke, and R. N. Adams, In vivo dynamics of norepinephrine releasereuptake in multiple terminal field regions of rat brain, J Neurochem, vol.63, pp.917-926, 1994.

M. L. Mundorf, J. D. Joseph, C. M. Austin, M. G. Caron, and R. M. Wightman, Catecholamine release and uptake in the mouse prefrontal cortex, J Neurochem, vol.79, pp.130-142, 2001.

D. L. Murphy, P. R. Moya, M. A. Fox, L. M. Rubenstein, J. R. Wendland et al., Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity, Philos Trans R Soc Lond B Biol Sci, vol.368, 2013.

H. Nakayama, K. Kitaichi, Y. Ito, K. Hashimoto, K. Takagi et al., The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats, Brain Res, vol.1184, pp.260-269, 2007.

M. Okuda, H. Saito, Y. Urakami, M. Takano, and K. Inui, cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2, Biochem Biophys Res Commun, vol.224, pp.500-507, 1996.

M. Okuda, Y. Urakami, H. Saito, and K. Inui, Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes, Biochim Biophys Acta, vol.1417, pp.224-231, 1999.

A. Polter, E. Beurel, S. Yang, R. Garner, L. Song et al., Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances, Neuropsychopharmacology, vol.35, pp.1761-1774, 2010.

R. D. Porsolt, G. Brossard, C. Hautbois, and S. Roux, Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice, Curr Protoc Neurosci, vol.14, 2001.

Z. Rahman, R. H. Ring, K. Young, B. Platt, Q. Lin et al., Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine, Brain Res, vol.1203, pp.68-78, 2008.

P. M. Rappold, M. Cui, A. S. Chesser, J. Tibbett, J. C. Grima et al., Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3, Proc Natl Acad Sci U S A, vol.108, pp.20766-20771, 2011.

H. Russ, J. Sonna, K. Keppler, S. Baunach, and E. Schomig, Cyanine-related compounds: a novel class of potent inhibitors of extraneuronal noradrenaline transport, Naunyn Schmiedebergs Arch Pharmacol, vol.348, pp.458-465, 1993.

H. Russ, K. Staust, F. Martel, M. Gliese, and E. Schomig, The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia, Eur J Neurosci, vol.8, pp.1256-1264, 1996.

E. Schomig, A. Lazar, and D. Grundemann, Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency, Handb Exp Pharmacol, pp.151-180, 2006.

T. Shang, A. V. Uihlein, J. Van-asten, B. Kalyanaraman, and C. J. Hillard, 1-Methyl-4phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3, J Neurochem, vol.85, pp.358-367, 2003.

S. Shugarts and L. Z. Benet, The role of transporters in the pharmacokinetics of orally administered drugs, Pharm Res, vol.26, pp.2039-2054, 2009.

I. S. Song, Y. Lee-do, M. H. Shin, H. Kim, Y. G. Ahn et al., Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition, PLoS One, vol.7, p.36637, 2012.

A. Surget, M. Saxe, S. Leman, Y. Ibarguen-vargas, S. Chalon et al., Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal, Biol Psychiatry, vol.64, pp.293-301, 2008.

A. Surget, A. Tanti, E. D. Leonardo, A. Laugeray, Q. Rainer et al., Antidepressants recruit new neurons to improve stress response regulation, Mol Psychiatry, vol.16, pp.1177-1188, 2011.

S. T. Szabo and P. Blier, Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus, Neuropsychopharmacology, vol.25, pp.845-857, 2001.

M. Takeda, S. Khamdang, S. Narikawa, H. Kimura, Y. Kobayashi et al., Human organic anion transporters and human organic cation transporters mediate renal antiviral transport, J Pharmacol Exp Ther, vol.300, pp.918-924, 2002.

D. Taubert, G. Grimberg, W. Stenzel, and E. Schomig, Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons, PLoS One, vol.2, p.385, 2007.

F. Thevenod, G. Ciarimboli, M. Leistner, N. A. Wolff, W. K. Lee et al., , 2013.

, Substrate-and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd2+, Mol Pharm, vol.10, pp.3045-3056

Y. M. Ulrich-lai and J. P. Herman, Neural regulation of endocrine and autonomic stress responses, Nat Rev Neurosci, vol.10, pp.397-409, 2009.

Y. Urakami, M. Akazawa, H. Saito, M. Okuda, and K. Inui, cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney, J Am Soc Nephrol, vol.13, pp.1703-1710, 2002.

V. Vialou, A. Amphoux, R. Zwart, B. Giros, and S. Gautron, Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation, J Neurosci, vol.24, pp.2846-2851, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-02008093

V. Vialou, L. Balasse, J. Callebert, J. M. Launay, B. Giros et al., Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice, J Neurochem, vol.106, pp.1471-1482, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-02008107

E. S. Vizi, G. Zsilla, M. G. Caron, and J. P. Kiss, Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors, J Neurosci, vol.24, pp.7888-7894, 2004.

H. K. Wayment, J. O. Schenk, and B. A. Sorg, Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition, J Neurosci, vol.21, pp.35-44, 2001.

B. Wenge, J. Geyer, and H. Bonisch, Oxybutynin and trospium are substrates of the human organic cation transporters, Naunyn Schmiedebergs Arch Pharmacol, vol.383, pp.203-208, 2011.

V. G. Wilson, M. Grohmann, and U. Trendelenburg, The uptake and O-methylation of 3H-(+/?)-isoprenaline in rat cerebral cortex slices, Naunyn Schmiedebergs Arch Pharmacol, vol.337, pp.397-405, 1988.

X. Wu, W. Huang, M. E. Ganapathy, H. Wang, R. Kekuda et al., , 2000.

, Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney, Am J Physiol Renal Physiol, vol.279, pp.449-458

X. Wu, R. Kekuda, W. Huang, Y. J. Fei, F. H. Leibach et al., Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain, J Biol Chem, vol.273, pp.32776-32786, 1998.

T. Wultsch, G. Grimberg, A. Schmitt, E. Painsipp, H. Wetzstein et al., Decreased anxiety in mice lacking the organic cation transporter 3, J Neural Transm, vol.116, pp.689-697, 2009.

S. U. Yanpallewar, K. Fernandes, S. V. Marathe, K. C. Vadodaria, D. Jhaveri et al., Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment, J Neurosci, vol.30, pp.1096-1109, 2010.

L. Zhang, M. E. Schaner, and K. M. Giacomini, Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa), J Pharmacol Exp Ther, vol.286, pp.354-361, 1998.

R. Zwart, S. Verhaagh, M. Buitelaar, C. Popp-snijders, and D. P. Barlow, Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice, Mol Cell Biol, vol.21, pp.4188-4196, 2001.